Oura buys AI primary care startup Counsel Health for $625M

A consumer hardware company just paid $625 million for an AI startup that is barely 20 months old. Oura, the Finnish smart ring maker, is acquiring Counsel Health, an AI-native primary care platform. TechCrunch reports the deal was announced on Tuesday. It is set to close before the end of 2027.

What Counsel Health does

Counsel Health runs a chat-based medical platform. Users ask AI questions about symptoms, medications and conditions. Licensed physicians stay in the loop for clinical decisions. The service was already built into the Oura app as of June 2026. CEO Muthu Alagappan said Counsel "built medical AI around trust, safety and responsibility," as quoted by TechCrunch. Counsel will fold into Oura. Alagappan will become Oura's chief clinical AI officer, and seventy Counsel staff come with him.

The numbers behind it

Counsel Health raised a $25 million Series A in June 2026, led by Andreessen Horowitz and GV, TechCrunch reports. Total prior funding was about $36 million. That makes the $625 million sale a 17x step up on its last round, inside 20 months.

Oura's own numbers, cited by TechCrunch, are large too. Q4 2026 revenue reached $533 million, a 153 percent rise year on year. Full year 2026 revenue was about $1.75 billion, up 92 percent. These are Oura's own figures. They have not been audited by a third party in this coverage.

The IPO context

Oura postponed a planned IPO of up to $2.2 billion in September 2026, citing market uncertainty. Spending $625 million on an acquisition in the same quarter is a reversal of that cautious signal. The deal says Oura is choosing to keep growing through purchases rather than public funding.

Health hardware brands have spent years framing themselves as wellness companies. They stayed careful on the correct side of medical claims. Buying an AI-native primary care startup moves Oura further into clinical territory. A consumer ring that measures sleep is one product. A consumer ring with an AI doctor attached is a different one. Regulators, clinicians and users will treat it differently.

What it means for other hardware companies

The pattern is now visible. Consumer AI health products need a medical layer that a chat interface alone cannot provide: a licensed clinician network, a clinical safety process, and accountability for wrong answers. Buying a team that already runs that layer is faster than building one. Other hardware brands with large installed bases will watch this price and timeline. That covers fitness trackers and smart scales. A team of 70 and a $25 million Series A fetched $625 million. That sets a reference point for anyone trying to sell, or buy, a similar capability in 2027.

Source

Reported by TechCrunch. The deal was announced via BusinessWire.